According to Cryo-Cell's latest financial reports the company's total liabilities are $72.04 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-11-30 | $72.25 M | 8.79% |
2022-11-30 | $66.41 M | 17.59% |
2021-11-30 | $56.47 M | 15.58% |
2020-11-30 | $48.86 M | -1.95% |
2019-11-30 | $49.83 M | -2.84% |
2018-11-30 | $51.29 M | 40.88% |
2017-11-30 | $36.41 M | 4.18% |
2016-11-30 | $34.95 M | 42.89% |
2015-11-30 | $24.46 M | 16.84% |
2014-11-30 | $20.93 M | 0.81% |
2013-11-30 | $20.76 M | -2.62% |
2012-11-30 | $21.32 M | -2.73% |
2011-11-30 | $21.92 M | 14.83% |
2010-11-30 | $19.09 M | -3.51% |
2009-11-30 | $19.78 M | 9.02% |
2008-11-30 | $18.15 M | -0.4% |
2007-11-30 | $18.22 M | 8.92% |
2006-11-30 | $16.73 M | 20.91% |
2005-11-30 | $13.83 M | 9.68% |
2004-11-30 | $12.61 M | 14.62% |
2003-11-30 | $11 M | 13.38% |
2002-11-30 | $9.7 M | 237.94% |
2001-11-30 | $2.87 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Omnicell
OMCL | $1.03 B | 1,340.58% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $0.57 B | 698.18% | ๐ญ๐ฐ Hong Kong |
CorVel Corporation
CRVL | $0.21 B | 193.50% | ๐บ๐ธ USA |